Skip to content
Research Article in Science Advances 2022- Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy
Home/Publications & abstracts/Research Article in Science Advances 2022- Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy
Research Article in Science Advances 2022- Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy
webmaster@ervaccinetechnologies.com2022-01-27T13:13:09+00:00
Share on your favorite plateform
Page load link